image showing signpost with text saying we are here to support your evidence-based product generation

A fee-based consultancy service to developers of:

  • pharmaceuticals
  • biopharmaceuticals
  • medical devices
  • diagnostics

We work with you in the early stages of product development. Our mission is to encourage you to consider the relative clinical and cost effectiveness of your products. These considerations can then inform your development strategy.

Make an enquiry

 

Our advice helps you prepare for NICE evaluations and supports discussions with payers and commissioners to enable market access.

Engaging with scientific advice can:

  • help you develop evidence that demonstrates the value of your product
  • provide detailed feedback on your clinical, economic development and evidence generation plans
  • provide insights from NICE-appointed experts
  • advise on the advantages and disadvantages of different options
  • help to integrate cost-effectiveness considerations into your evidence generation plans
  • help companies understand health technology assessments, and the perspective of decision makers, at our educational seminars and events.

To find out more about our wide range of services, choose from one of the options below and read our frequently asked questions.

You can find out more about the team on our biographies page.

AdviSeMe prize open

  • Are you a healthcare SME, academic research group or charity?
  • Are you developing a transformative healthcare product for the NHS?
  • Could your product improve health outcomes or save money for the NHS?
  • Would you like our input on your evidence development plans?

If so, apply for the NICE Advise Me prize – win a light scientific advice service worth £15,000.

Find out more


Image of a pill

Pharmaceutical products

Standard scientific advice

Detailed advice from NICE and a panel of appointed experts.

 

NICE-MHRA scientific advice

Joint regulatory advice from the Medicines and Healthcare products Regulatory Agency and NICE Scientific Advice.

 

HTA-EMA scientific advice

Advice from the European Medicines Agency in parallel with NICE and other European Health Technology Assessment bodies.

 

Advice for small and medium-sized companies

A concise, more affordable version of our standard advice process.

Read our FAQs
Image of a heart beat

Devices and diagnostics

Medtech Early Technical Assessment (META) tool

An affordable platform to help product developers understand what evidence is needed to make a convincing case to payers and commissioners for their technology.

 

Standard scientific advice

Detailed advice from NICE and a panel of appointed experts.

 

Advice for small and medium-sized companies

A concise, more affordable version of our standard advice process.

 

NICE-FDA scientific advice

Advice from the United States’ Food and Drug Administration PCTF in parallel with NICE. Contact us for further information.

Read our FAQs
Image of a seminar

Seminars, events and speaking engagements

24 August 2017 - London

Advanced Pharmaceutical Seminar

Do you want:

  • deeper insight into the technology appraisal process and methods
  • practical experience of engaging with a NICE technology appraisal
  • to understand the factors that influence our committee's decisions?

Then come along to this one-day seminar.

18 September 2017 - Manchester

Foundation Seminar

Do you want to:

  • learn how we develop our guidance
  • find out about our processes and programmes
  • gain insight into what influences committee decision making?

Then come along to our one-day seminar. It's designed for those with no previous knowledge in the field.

See all events